China Resources Double-Crane to Acquire 23.5% Stake in Lier Chemical for 5.656 Billion Yuan

Corporate Action
โดย 财中社·Read original
Summary · why it matters

China Resources Double-Crane, a non-wholly-owned subsidiary of China Resources Pharmaceutical, has signed a share purchase agreement with Jiuyuan Group and Chemical Materials Technology to acquire 188 million shares of Lier Chemical for 5.656 billion yuan, representing approximately 23.50% of Lier Chemical's total share capital. Upon completion of the transaction, China Resources Double-Crane will become the largest shareholder of Lier Chemical, and Lier Chemical will be accounted for as a non-wholly-owned subsidiary of China Resources Pharmaceutical. Lier Chemical is primarily engaged in the research, development, production, and sale of highly effective, low-toxicity, low-residue, and safe active ingredients for pesticides and pesticide formulations. Prior to the acquisition, its de facto controller was the China Academy of Engineering Physics, which controlled approximately 32.20% of the equity interest in Lier Chemical through Jiuyuan Group and Chemical Materials Technology.

Impact on stocks 4

Biotech & Genomic Medicine▲ · 1 stocks
Others▲ · 3 stocks
Lier Chemical Co Ltd
002258
± MixedCapitalrelevance

Lier Chemical is being acquired; impact depends on terms and future integration, but it gains a major shareholder.

Off-coverage companies 2

Sichuan Jiuyuan Investment Holding Group Co LtdPrivate± Mixed
relevance

四川化材科技有限公司Private± Mixed
relevance

© 2026 MarketDXNews